<SEC-DOCUMENT>0001104659-16-163803-index.html : 20161223
<SEC-HEADER>0001104659-16-163803.hdr.sgml : 20161223
<ACCEPTANCE-DATETIME>20161223180209
ACCESSION NUMBER:		0001104659-16-163803
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20161018
FILED AS OF DATE:		20161223
DATE AS OF CHANGE:		20161223

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		AESCHENVORSTADT 36
		CITY:			BASEL
		STATE:			V8
		ZIP:			4051
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		AESCHENVORSTADT 36
		CITY:			BASEL
		STATE:			V8
		ZIP:			4051

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Woiwode Thomas
		CENTRAL INDEX KEY:			0001619294

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		162069509

	MAIL ADDRESS:	
		STREET 1:		ONE SANSOME STREET
		STREET 2:		SUITE 3630
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>a3a.xml
<DESCRIPTION>3/A
<TEXT>
Document 1 - file: a3a.html

Document 1 - RAW XML: a3a.xml

</DOCUMENT>
</SEC-DOCUMENT>